Biotechnology Index NYSE ETF (FBT)

$144.97 2.04 (1.43%)

16:10 EDT FBT Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 11.02M

PE Ratio -

EPS -

Volume (Avg. Vol.) 18,167

Day's Range $143.82 - $146.59

52-Week Range $130.27 - $161.41

Dividend & Yield N/A (N/A)

FBT Stock Predictions, Articles, and Biotechnology Index NYSE ETF News

From the Web

Biotech ETFs That Outperformed Last Week

From Talk Markets Dec 20, 2021

Though the broad U.S. market saw a tumultuous ride last week with most of the sectors in red, biotechnology was the biggest gainer.

Biotech ETFs To Benefit From Latest Booster Update

From Talk Markets Aug 21, 2021

Vaccine makers like Moderna and Pfizer have reasons to cheer the update with regard to the application of boosters. The U.S. government announced plans to make COVID-19 vaccine boosters available from Sept. 20 onward. Here's ETFs that may benefit.

Q2 Growth 'Nothing Short Of Virtuous': Economist

From Benzinga Jul 29, 2021

The coronavirus pandemic that began in 2020 and is persisting today has led many investors to hold poor market expectations. But maybe they shouldn’t be so pessimistic. What...

Top-Performing Biotech ETFs of Last Week

From Talk Markets Jun 15, 2021

Investors may want to tap the bullishness in the biotech sector with the best biotech ETFs of last week.

5 Top ETFs With Exposure To Biogen

From Talk Markets Jun 7, 2021

Here is a look at five ETFs with large exposure to Biogen shares.

5 Top ETFs With Exposure To Biogen

From Benzinga Jun 7, 2021

For the first time in 18 years, there was a new treatment for Alzheimer’s Disease approved by the FDA. Aducanumab from Biogen Inc (NASDAQ: BIIB) was approved as a drug that...

ADVERTISEMENT